BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of neuromuscular blocking and circulatory effects of vecuronium bromide and pancuronium bromide by a double blind study]. 1986

N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
June 1983, British journal of anaesthesia,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
[Influence of sevoflurane on the neuromuscular blocking effects of vecuronium and pancuronium].
February 1987, Masui. The Japanese journal of anesthesiology,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
Experimental and clinical study of the effects of pancuronium bromide, a neuromuscular blocking agent.
September 1972, Arzneimittel-Forschung,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
Pancuronium bromide: a double-blind study in children.
January 1973, Anesthesia and analgesia,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
November 1985, British journal of anaesthesia,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
[Comparative clinical study between vecuronium bromide and pancuronium bromide].
January 1986, Revista espanola de anestesiologia y reanimacion,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
[Comparative study between vecuronium bromide and pancuronium].
January 1986, Revista espanola de anestesiologia y reanimacion,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
September 1984, British journal of anaesthesia,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
[A clinical and experimental study on potentiation with sevoflurane of neuromuscular blocking effects of vecuronium and pancuronium].
August 1988, Masui. The Japanese journal of anesthesiology,
N Sugai, and Y Inada, and Y Goto, and Y Hashimoto, and K Kaya, and H Suzuki, and S Iwai, and S Murakami, and F Kosaka, and A Ebihara
[Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
September 2006, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!